DIVERSIFIED HEALTHCARE T - DHC 5 5/8 08/01/42 (DHCNI) Fundamental Analysis & Valuation

NASDAQ:DHCNI • US25525P2065

Current stock price

17.9 USD
+0.22 (+1.24%)
At close:
17.9 USD
0 (0%)
After Hours:

This DHCNI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. DHCNI Profitability Analysis

1.1 Basic Checks

  • In the past year DHCNI has reported negative net income.
  • In the past year DHCNI has reported a negative cash flow from operations.
  • DHCNI had negative earnings in 4 of the past 5 years.
  • In multiple years DHCNI reported negative operating cash flow during the last 5 years.
DHCNI Yearly Net Income VS EBIT VS OCF VS FCFDHCNI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M -400M

1.2 Ratios

  • DHCNI's Return On Assets of -6.56% is on the low side compared to the rest of the industry. DHCNI is outperformed by 85.37% of its industry peers.
  • DHCNI has a Return On Equity of -17.16%. This is amonst the worse of the industry: DHCNI underperforms 81.30% of its industry peers.
Industry RankSector Rank
ROA -6.56%
ROE -17.16%
ROIC N/A
ROA(3y)-6.38%
ROA(5y)-3.36%
ROE(3y)-16.21%
ROE(5y)-8.53%
ROIC(3y)N/A
ROIC(5y)N/A
DHCNI Yearly ROA, ROE, ROICDHCNI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 -5 -10 -15

1.3 Margins

  • With a Gross Margin value of 18.11%, DHCNI is not doing good in the industry: 92.68% of the companies in the same industry are doing better.
  • DHCNI's Gross Margin has declined in the last couple of years.
  • DHCNI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 18.11%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.03%
GM growth 5Y-5.67%
DHCNI Yearly Profit, Operating, Gross MarginsDHCNI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. DHCNI Health Analysis

2.1 Basic Checks

  • DHCNI does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • DHCNI has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for DHCNI has been increased compared to 5 years ago.
  • The debt/assets ratio for DHCNI has been reduced compared to a year ago.
DHCNI Yearly Shares OutstandingDHCNI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
DHCNI Yearly Total Debt VS Total AssetsDHCNI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.2 Solvency

  • DHCNI has an Altman-Z score of 0.34. This is a bad value and indicates that DHCNI is not financially healthy and even has some risk of bankruptcy.
  • DHCNI has a Altman-Z score of 0.34. This is comparable to the rest of the industry: DHCNI outperforms 42.28% of its industry peers.
  • DHCNI has a Debt/Equity ratio of 1.44. This is a high value indicating a heavy dependency on external financing.
  • DHCNI's Debt to Equity ratio of 1.44 is in line compared to the rest of the industry. DHCNI outperforms 44.72% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.44
Debt/FCF N/A
Altman-Z 0.34
ROIC/WACCN/A
WACC8.6%
DHCNI Yearly LT Debt VS Equity VS FCFDHCNI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B

2.3 Liquidity

  • A Current Ratio of 1.56 indicates that DHCNI should not have too much problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 1.56, DHCNI belongs to the top of the industry, outperforming 82.11% of the companies in the same industry.
  • A Quick Ratio of 1.56 indicates that DHCNI should not have too much problems paying its short term obligations.
  • DHCNI has a better Quick ratio (1.56) than 82.93% of its industry peers.
Industry RankSector Rank
Current Ratio 1.56
Quick Ratio 1.56
DHCNI Yearly Current Assets VS Current LiabilitesDHCNI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. DHCNI Growth Analysis

3.1 Past

  • The earnings per share for DHCNI have decreased by -4.76% in the last year.
  • Looking at the last year, DHCNI shows a small growth in Revenue. The Revenue has grown by 2.84% in the last year.
  • DHCNI shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -1.18% yearly.
EPS 1Y (TTM)-4.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%75%
Revenue 1Y (TTM)2.84%
Revenue growth 3Y6.21%
Revenue growth 5Y-1.18%
Sales Q2Q%-0.01%

3.2 Future

  • DHCNI is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 23.95% yearly.
  • The Revenue is expected to grow by 4.03% on average over the next years.
EPS Next Y49.5%
EPS Next 2Y23.95%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year2.55%
Revenue Next 2Y4.03%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
DHCNI Yearly Revenue VS EstimatesDHCNI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
DHCNI Yearly EPS VS EstimatesDHCNI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 -1

More info and screens

Find the best growth stocksShow best growing peers

1

4. DHCNI Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for DHCNI. In the last year negative earnings were reported.
  • Also next year DHCNI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DHCNI Price Earnings VS Forward Price EarningsDHCNI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 60

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, DHCNI is valued expensively inside the industry as 90.24% of the companies are valued cheaper.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 28.22
DHCNI Per share dataDHCNI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

  • A more expensive valuation may be justified as DHCNI's earnings are expected to grow with 23.95% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y23.95%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

1

5. DHCNI Dividend Analysis

5.1 Amount

  • With a yearly dividend of 0.55%, DHCNI is not a good candidate for dividend investing.
  • With a Dividend Yield of 0.55, DHCNI pays less dividend than the industry average, which is at 7.59. 92.68% of the companies listed in the same industry pay a better dividend than DHCNI!
  • With a Dividend Yield of 0.55, DHCNI pays less dividend than the S&P500 average, which is at 1.82.
Industry RankSector Rank
Dividend Yield 0.55%

5.2 History

  • The dividend of DHCNI decreases each year by -25.96%.
  • DHCNI has been paying a dividend for over 5 years, so it has already some track record.
  • DHCNI has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)-25.96%
Div Incr Years0
Div Non Decr Years3
DHCNI Yearly Dividends per shareDHCNI Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6 0.8 1

5.3 Sustainability

  • The earnings of DHCNI are negative and hence is the payout ratio. DHCNI will probably not be able to sustain this dividend level.
DP-3.38%
EPS Next 2Y23.95%
EPS Next 3YN/A
DHCNI Yearly Income VS Free CF VS DividendDHCNI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M -400M

More info and screens

Find the best dividend stocksShow peers with best dividend

DHCNI Fundamentals: All Metrics, Ratios and Statistics

DIVERSIFIED HEALTHCARE T - DHC 5 5/8 08/01/42

NASDAQ:DHCNI (3/13/2026, 8:21:09 PM)

After market: 17.9 0 (0%)

17.9

+0.22 (+1.24%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)02-23
Earnings (Next)05-04
Inst Owners79.52%
Inst Owner ChangeN/A
Ins Owners0.48%
Ins Owner ChangeN/A
Market Cap4.33B
Revenue(TTM)1.54B
Net Income(TTM)-285.89M
Analysts74.29
Price Target16.78 (-6.26%)
Short Float %0.02%
Short Ratio1.22
Dividend
Industry RankSector Rank
Dividend Yield 0.55%
Yearly Dividend0.04
Dividend Growth(5Y)-25.96%
DP-3.38%
Div Incr Years0
Div Non Decr Years3
Ex-Date01-15
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-82.03%
Min EPS beat(2)-213.15%
Max EPS beat(2)49.08%
EPS beat(4)2
Avg EPS beat(4)-28.15%
Min EPS beat(4)-213.15%
Max EPS beat(4)122.5%
EPS beat(8)3
Avg EPS beat(8)-9.87%
EPS beat(12)5
Avg EPS beat(12)-4.94%
EPS beat(16)5
Avg EPS beat(16)-13.8%
Revenue beat(2)1
Avg Revenue beat(2)-1.84%
Min Revenue beat(2)-4.35%
Max Revenue beat(2)0.67%
Revenue beat(4)1
Avg Revenue beat(4)-1.05%
Min Revenue beat(4)-4.35%
Max Revenue beat(4)0.67%
Revenue beat(8)2
Avg Revenue beat(8)-0.93%
Revenue beat(12)4
Avg Revenue beat(12)-0.74%
Revenue beat(16)5
Avg Revenue beat(16)-0.93%
PT rev (1m)-3.51%
PT rev (3m)-10.61%
EPS NQ rev (1m)-3.45%
EPS NQ rev (3m)-3.45%
EPS NY rev (1m)4.35%
EPS NY rev (3m)4.35%
Revenue NQ rev (1m)-2.43%
Revenue NQ rev (3m)-2.25%
Revenue NY rev (1m)-1.05%
Revenue NY rev (3m)-0.74%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.82
P/FCF N/A
P/OCF N/A
P/B 2.6
P/tB 2.6
EV/EBITDA 28.22
EPS(TTM)-1.1
EYN/A
EPS(NY)-0.56
Fwd EYN/A
FCF(TTM)-0.69
FCFYN/A
OCF(TTM)-0.08
OCFYN/A
SpS6.35
BVpS6.88
TBVpS6.88
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -6.56%
ROE -17.16%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 18.11%
FCFM N/A
ROA(3y)-6.38%
ROA(5y)-3.36%
ROE(3y)-16.21%
ROE(5y)-8.53%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.03%
GM growth 5Y-5.67%
F-Score6
Asset Turnover0.35
Health
Industry RankSector Rank
Debt/Equity 1.44
Debt/FCF N/A
Debt/EBITDA 10.3
Cap/Depr 56.06%
Cap/Sales 9.55%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.56
Quick Ratio 1.56
Altman-Z 0.34
F-Score6
WACC8.6%
ROIC/WACCN/A
Cap/Depr(3y)69.85%
Cap/Depr(5y)90%
Cap/Sales(3y)13.23%
Cap/Sales(5y)17.07%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-4.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%75%
EPS Next Y49.5%
EPS Next 2Y23.95%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)2.84%
Revenue growth 3Y6.21%
Revenue growth 5Y-1.18%
Sales Q2Q%-0.01%
Revenue Next Year2.55%
Revenue Next 2Y4.03%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y45.02%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1793.22%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-86.01%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-117.48%
OCF growth 3YN/A
OCF growth 5YN/A

DIVERSIFIED HEALTHCARE T - DHC 5 5/8 08/01/42 / DHCNI Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for DIVERSIFIED HEALTHCARE T - DHC 5 5/8 08/01/42?

ChartMill assigns a fundamental rating of 2 / 10 to DHCNI.


What is the valuation status of DIVERSIFIED HEALTHCARE T - DHC 5 5/8 08/01/42 (DHCNI) stock?

ChartMill assigns a valuation rating of 1 / 10 to DIVERSIFIED HEALTHCARE T - DHC 5 5/8 08/01/42 (DHCNI). This can be considered as Overvalued.


How profitable is DIVERSIFIED HEALTHCARE T - DHC 5 5/8 08/01/42 (DHCNI) stock?

DIVERSIFIED HEALTHCARE T - DHC 5 5/8 08/01/42 (DHCNI) has a profitability rating of 0 / 10.


How financially healthy is DIVERSIFIED HEALTHCARE T - DHC 5 5/8 08/01/42?

The financial health rating of DIVERSIFIED HEALTHCARE T - DHC 5 5/8 08/01/42 (DHCNI) is 3 / 10.


What is the expected EPS growth for DIVERSIFIED HEALTHCARE T - DHC 5 5/8 08/01/42 (DHCNI) stock?

The Earnings per Share (EPS) of DIVERSIFIED HEALTHCARE T - DHC 5 5/8 08/01/42 (DHCNI) is expected to grow by 49.5% in the next year.